Biosimilars Market is Expected to Reach USD 1,26,019.67 Million By 2032
17 août 2023 11h00 HE
|
Precedence Research
Ottawa, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The global biosimilars market revenue is projected to reach around USD 76,920.96 million by 2029, a study published by Towards Healthcare a sister firm of...
Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.
03 juil. 2023 08h30 HE
|
Coherus BioSciences, Inc.
–$995 per carton (two 40 mg/0.8 mL autoinjectors) represents a discount of more than 85% compared to Humira® – – YUSIMRY™ meets high unmet need by providing patients, employers, physicians and...
Psoriasis Treatment Market Size to reach USD 44 Bn by 2031, growing at a CAGR of 8.7% from 2022-2031: TMR Report
03 juil. 2023 07h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 03, 2023 (GLOBE NEWSWIRE) -- The global psoriasis treatment market is estimated to flourish at a CAGR of 8.7% from 2022 to 2031. According to Transparency...
Nearly One Year Post-Launch Biogen & Coherus Biosciences’ Ranibizumab Biosimilars Have Yet to Make a Splash in Their Respective Retina Markets
23 juin 2023 11h41 HE
|
Spherix Global Insights
Exton, Pennsylvania, June 23, 2023 (GLOBE NEWSWIRE) -- Spherix has been tracking ophthalmologists’ attitudes and perceptions around biosimilars in their Special Topix: Ophthalmology Biosimilars...
Biosimilars Market Size to Cross USD 85 Bn Valuation by 2031 | Transparency Market Research
18 avr. 2023 14h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 19, 2023 (GLOBE NEWSWIRE) -- The global biosimilars market stood at USD 20.4 Bn in 2021 and is expected to surpass USD 85 Bn by 2031, expanding at a CAGR...
Cell Culture Market to Hit USD 27.6 Bn by 2031 | Transparency Market Research
14 avr. 2023 08h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The global cell culture market stood at USD 10.5 Bn in 2020 and the global market is projected to reach USD 27.6 Bn by 2031....
Biosimilars Market is Anticipated to Grow at a CAGR of 14.1% from 2023-2032 due to Increasing Incidences of Chronic Diseases
28 févr. 2023 05h28 HE
|
Market.Us
Pune, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the global biosimilars market accounted for USD 9.5 billion in 2022 and is projected to reach USD 34.4 billion by 2032, exhibiting a...
Biosimilars Market Size Worth ($136+ Billion by 2028) Lead by Intravenous Segment (36% CAGR) - Exclusive Research Study by The Insight Partners
27 févr. 2023 07h39 HE
|
The Insight Partners
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Biosimilars Market Size, Share, Growth, Strategy & Global Forecast to 2028 - COVID-19 Impact and Global Analysis...
Biopharmaceuticals Contract Manufacturing Market Research 2023-2030 'Reports Insights'
27 févr. 2023 07h00 HE
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Biopharmaceuticals Contract Manufacturing Market is projected to grow at a CAGR of 5.6% from 2023 to 2030, reaching a value of USD 27.6 Billion by...
Coherus BioSciences Reports Third Quarter 2022 Results and Provides Business Update
08 nov. 2022 16h01 HE
|
Coherus BioSciences, Inc.
– UDENYCA® net sales of $45.4 million in the third quarter 2022 –– CIMERLI™ launched in the United States on October 3rd –– Planning underway for 2023 commercial launches of toripalimab, YUSIMRY™ and...